Jaguar Health, Inc.: Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea in Dogs
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from FDASAN FRANCISCO, CA / ACCESSWIRE / April 27, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX), under its Jaguar
Source: finanznachrichten.de